You are here
Harpoon Therapeutics to Present at SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today that Gerald McMahon, Ph.D., President and Chief Executive Officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at 9:30 a.m. ET (6:30 a.m. PT) at the Lotte New York Palace in New York City. Management will also be available that day to meet with investors at the conference.
Wednesday, February 20, 2019 - 07:30